Skip to main content
Terug
Watch Compare

Biofrontera Inc.

Datakwaliteit: 100%
Ook genoteerd als BFRIW NASDAQ
BFRI
NASDAQ Manufacturing Chemicals
€ 1,03
▼ € 0,01 (-0,96%)
Marktkapitalisatie: 12,17 M
Prijs
€ 1,05
Marktkapitalisatie
12,17 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 14,69% annually over 5 years — strong growth
Negative free cash flow of -13,36 M
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
14,69%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)11,75%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-540,54%
Net Margin-25,26%
Op. Margin-27,21%

Veiligheid

Debt / Equity
N/A
Current Ratio1,15
Interest CoverageN/A

Waardering

PE (TTM|NTM|2027)
-1,16 | 7,36 | 7,50
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -1,2 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -25,3 -41,5
Rev Growth 5Y % 14,7 1,8
D/E — 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 1,03
+482.5%
Koersdoel
€ 6,00
€ 3,00
€ 6,00
€ 9,00
Vooruitzicht
Forward K/W 7,36
Forward WPA € 0,14
Omzet Sch. 54,70 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,14
€ 0,14 – € 0,14
 54,70 M 1
FY2026 -€ 0,06
-€ 0,06 – -€ 0,06
 46,76 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,10 € 0,50 +398,1%
Q32025 -€ 0,56 -€ 0,57 -1,6%
Q22025 -€ 0,39 -€ 0,57 -45,1%
Q12025 -€ 0,29 -€ 0,51 -75,3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 11,75% Revenue Growth (3Y) 10,64%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 14,69% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 41,71 M Net Income (TTM) -10,54 M
ROE N/A ROA -59,26%
Gross Margin N/A Operating Margin -27,21%
Net Margin -25,26% Free Cash Flow (TTM) -13,36 M
ROIC -540,54% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,15
Interest Coverage N/A Asset Turnover 2,35
Working Capital 1,86 M Tangible Book Value -2,60 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,16 Forward P/E 7,36
P/B Ratio N/A P/S Ratio 0,29
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,22 Fwd Earnings Yield 13,59%
FCF Yield -109,78%
Market Cap 12,17 M Enterprise Value 8,76 M
Per Share
EPS (Diluted TTM) -1,04 Revenue / Share 3,58
FCF / Share -1,15 OCF / Share -1,15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 126,83%
SBC-Adj. FCF -14,31 M Growth Momentum -2,94

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 41,71 M 37,32 M 34,07 M 28,67 M 24,10 M
Net Income -10,54 M -17,76 M -20,13 M -640.000,0 -37,71 M
EPS (Diluted) -1,04 -3,22 -13,02 — —
Gross Profit — — — — —
Operating Income -11,35 M -17,21 M -22,68 M -18,58 M -25,20 M
EBITDA — — — — —
R&D Expenses 3,72 M 2,09 M 77.000,0 — —
SG&A Expenses 37,75 M — 38,98 M 35,14 M 36,51 M
D&A 138.000,0 600.000,0 — — —
Interest Expense — — 220.000,0 195.000,0 344.000,0
Income Tax 25.000,0 22.000,0 14.000,0 32.000,0 56.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28,56 M 22,10 M 27,93 M 50,88 M 53,22 M
Total Liabilities 18,08 M 17,67 M 23,14 M 27,01 M 41,88 M
Shareholders' Equity 10,48 M 4,43 M 4,79 M 23,88 M 11,34 M
Total Debt — 3,90 M 3,90 M — —
Cash & Equivalents 6,39 M 5,91 M 1,34 M 17,21 M 24,55 M
Current Assets 18,08 M 20,70 M 23,08 M 43,14 M 46,42 M
Current Liabilities 11,90 M 12,02 M 18,09 M 20,89 M 13,84 M

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Value Price/Sales Ratio Focus (Ken Fisher)
#198 of 245
28

Recente Activiteit

Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026